ABSTRACT
BACKGROUND: In the European Union, around 5 million people are affected by psychotic disorders, and approximately 30%-50% of people with schizophrenia have treatment-resistant schizophrenia (TRS). Mobile health (mHealth) interventions may be effective in preventing relapses, increasing treatment adherence, and managing some of the symptoms of schizophrenia. People with schizophrenia seem willing and able to use smartphones to monitor their symptoms and engage in therapeutic interventions. mHealth studies have been performed with other clinical populations but not in populations with TRS. OBJECTIVE: The purpose of this study was to present the 3-month prospective results of the m-RESIST intervention. This study aims to assess the feasibility, acceptability, and usability of the m-RESIST intervention and the satisfaction among patients with TRS after using this intervention. METHODS: A prospective multicenter feasibility study without a control group was undertaken with patients with TRS. This study was performed at 3 sites: Sant Pau Hospital (Barcelona, Spain), Semmelweis University (Budapest, Hungary), and Sheba Medical Center and Gertner Institute of Epidemiology and Health Policy Research (Ramat-Gan, Israel). The m-RESIST intervention consisted of a smartwatch, a mobile app, a web-based platform, and a tailored therapeutic program. The m-RESIST intervention was delivered to patients with TRS and assisted by mental health care providers (psychiatrists and psychologists). Feasibility, usability, acceptability, and user satisfaction were measured. RESULTS: This study was performed with 39 patients with TRS. The dropout rate was 18% (7/39), the main reasons being as follows: loss to follow-up, clinical worsening, physical discomfort of the smartwatch, and social stigma. Patients' acceptance of m-RESIST ranged from moderate to high. The m-RESIST intervention could provide better control of the illness and appropriate care, together with offering user-friendly and easy-to-use technology. In terms of user experience, patients indicated that m-RESIST enabled easier and quicker communication with clinicians and made them feel more protected and safer. Patients' satisfaction was generally good: 78% (25/32) considered the quality of service as good or excellent, 84% (27/32) reported that they would use it again, and 94% (30/32) reported that they were mostly satisfied. CONCLUSIONS: The m-RESIST project has provided the basis for a new modular program based on novel technology: the m-RESIST intervention. This program was well-accepted by patients in terms of acceptability, usability, and satisfaction. Our results offer an encouraging starting point regarding mHealth technologies for patients with TRS. TRIAL REGISTRATION: ClinicalTrials.gov NCT03064776; https://clinicaltrials.gov/ct2/show/record/NCT03064776. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.1136/bmjopen-2017-021346.
ABSTRACT
Reducing ineffective practices is one way to ensure high-quality and efficient healthcare for the population. For this reason, several initiatives have been implemented worldwide to reduce low-value care. This article describes the experience of the Essencial project, a multifaceted deadoption strategy implemented in the Catalan primary care system. Lessons learnt from this project include the importance of considering the local context in deadoption strategies, providing adequate training and communication material to patients and clinicians and supporting the key role of clinical champions. Given the knowledge gaps regarding the conditions for successful deadoption strategies, the Catalan experience could provide enlightenment on how to implement, evaluate and sustain a large-scale collaborative deadoption strategy in primary healthcare.
Subject(s)
Communication , Delivery of Health Care , Humans , Primary Health CareABSTRACT
Resumen: Objetivo: Conocer el nivel de participación de pacientes, usuarios y ciudadanos en los comités de ética de la investigación (CEI) y los comités de ética asistencial (CEA) acreditados en Cataluña. Material y métodos: Estudio descriptivo transversal en una muestra oportunista de 30 CEI y CEA. Se administró un cuestionario dirigido a los presidentes y al representante de los usuarios o ciudadanos (miembro lego). Para la interpretación de los resultados se analizó medias y desviación estándar. Las respuestas a las preguntas de texto abierto se analizaron mediante un análisis cualitativo del contenido. Resultados: Del total de los 30 comités de ética (CEI y CEA) contactados, 12 (40%) aceptaron participar. En total se realizaron 15 entrevistas (9 miembros de CEI y 6 miembros de CEA): 8 presenciales, 4 telefónicamente y 3 contestadas por correo electrónico. Resultados de los CEI: del total de 7 CEI entrevistados, 2 tenían representación ciudadana en su comité. El perfil correspondía a una mujer, de profesión administrativa y a un hombre de profesión auditor contable, ambos de más de 50 años. Resultados de los CEA: de los 5 CEA que participaron, 2 declararon tener representación de la ciudanía. El perfil correspondía a una mujer, de profesión administrativa y a un hombre de profesión profesor, ambos de más de 50 años. Discusión: Actualmente hay poca representación de la ciudadanía/pacientes en los comités éticos institucionales. Constituye un tema actual de debate la necesidad de incorporar el punto de vista del ciudadano/paciente, habiendo, sin embargo, un desconocimiento sobre el perfil más idóneo y en discusión su representatividad.
Abstract: Aim: To know the level of participation of patients, users and civilians in scientific ethical review committees (SERC) and health care ethical review committees (HCERC) accredited in Catalonian. Materials and methods: Descriptive transversal study using an opportunistic sample of 30 SERC and HCERC. A questionnaire was filled out addressed to presidents and consumer or civilian (lay member) representatives. For the interpretation of results means and standard deviations were analyzed. Answers to open texts questions were analyzed using qualitative content analysis. Results: 12 committees (40%) accepted to participate; 15 interviews were carried out (9 SERC members and 6 HCERC members): 8 person to person, 4 by phone and 3 by email. SERC Results: Of 7 SERC interviewed, 2 have a civilian representative in the committee. The profile was a woman of administrative profession and an auditor accountant man, both older than 50 years. HCERC Results: Of 5 HCERC participating, 2 declared having a civilian representative. The profile was a woman of administrative profession and a man teacher, both older than 50 years. Discussion: Currently, there is low civilian/patient representation in institutional ethical review committees. Today, the need to incorporate the point of view of the civilian/patient is a debatable issue, being unknown the suitable profile and their representativeness is under discussion.
Resumo: Objetivo: Conhecer o nível de participação de pacientes, usuários e cidadãos em comitês de ética de pesquisa (CEI) e as comissões de ética de cuidados de saúde (CEA) acreditados na Catalunha. Material e métodos: Estudo descritivo, transversal em uma amostra oportunista de 30 CEI e CEA. Um questionário dirigido aos presidentes e representante dos usuários ou cidadãos (membro de leigo) foi administrado. Para a interpretação dos resultados foi feita uma análise que incluiu as médias e o desvio-padrão. Analisaram-se as respostas às perguntas do texto aberto com uma análise qualitativa do conteúdo. Resultados: Do total dos 30 comitês de ética (CEI e CEA) contatados, 12 (40%) concordaram em participar. No total foram realizadas 15 entrevistas (9 membros do CEI e 6 membros da CEA). De todas as entrevistas realizadas, 8 foram presenciais, 4 foram realizadas por telefone e 3 foram respondidas por e-mail. Resultados da CEI: do total de 7 entrevistados da CEI, 2 tinham representação cidadã na sua Comissão. O perfil correspondia a uma mulher, de carreira administrativa e a um home de profissão auditor contábil, ambos com mais de 50 anos. Resultados da CEA: dos 5 CEA que participaram, 2 declararam ter representação cidadã. O perfil correspondente era de uma mulher, de carreira administrativa e a um homem professor, ambos com mais de 50 anos. Discussão: Atualmente há pouca representação dos cidadãos/pacientes em comitês de ética institucionais. A necessidade de incorporar o ponto de vista do cidadão/paciente constitui um tema atual de discussão, no entanto, falta conhecimento sobre o perfil mais adequado e discussão sua representatividade.
Subject(s)
Humans , Ethics Committees , Community Participation , Health Services Research , Spain , Epidemiology, Descriptive , Cross-Sectional Studies , Surveys and QuestionnairesABSTRACT
OBJECTIVES: To explore the opinions of health professionals with experience of the European Patient Smart Open Services (epSOS) system regarding the epSOS services perceived utility, potential impact and main barriers and facilitators to its use. METHODS: Qualitative study design involving focus groups with health care professionals with experience of epSOS system. A semi-structured topic guide was developed to guide the discussion. RESULTS: epSOS services were seen as interesting intuitive services and easy to operate. The greatest impact was in terms of positive impact on communication, clinical safety and patient management. Data reliability, difficulties in accessing the service and aspects related to information technology architecture were considered the most relevant barriers. CONCLUSION: This study has provided insights into the strengths and limitations of two new eHealth services for use across countries within the European Union, and has provided indications of how those services could be improved.
Subject(s)
Attitude of Health Personnel , Communication Barriers , Electronic Health Records , Electronic Prescribing , European Union , Pharmacists , Physicians , Adult , Female , Focus Groups , Humans , International Classification of Diseases , Language , Male , Middle Aged , Physician-Patient Relations , Program EvaluationABSTRACT
OBJECTIVES: Since 1997, members of the International Network of Agencies for Health Technology Assessment (INAHTA) have collaborated on a Joint Project to track the diffusion, evaluation, and clinical policy of positron emission tomography (PET). Part 2 of this updated Joint Project report summarizes HTA-based strategies for directing the clinical use of PET and a discussion on the value of HTA in managing the diffusion of high cost diagnostic technologies, which were presented at an INAHTA-sponsored workshop at the Health Technology Assessment International Annual Meeting in 2004 on strategies for managing high cost diagnostic technologies. METHODS: A summary of the workshop proceedings is presented. CONCLUSIONS: Sharing assessment work, universal agreement in assessment conclusions, stakeholder input, and modeling techniques help manage the uncertainty in the evidence base while targeting clinical use of PET toward the most promising indications. Emphasis on HTA findings, linkage between financing of clinical PET and outcome evaluation, and targeted dissemination of scientific findings empower providers to reduce unnecessary utilization and contain costs within a quality improvement framework. Above all, a trustworthy source of HTA information and a process that is conducive to using scientific evidence as the basis for decision making are essential for managing the diffusion of complex and costly diagnostic technologies in patient care.
Subject(s)
Diffusion of Innovation , Positron-Emission Tomography/instrumentation , Technology Assessment, Biomedical/organization & administration , Capital Financing/organization & administration , Health Policy , Humans , International Cooperation , Positron-Emission Tomography/economicsABSTRACT
No disponible
Subject(s)
Humans , Epidemiologic Studies , Epidemiologic Research Design , Data Collection/methods , 28573 , Random Allocation , Placebos , Case-Control Studies , Double-Blind Method , Single-Blind Method , Randomized Controlled Trials as Topic/methodsABSTRACT
No disponible
